Search Beyond News…

Vector Science and Therapeutics hires RedChip for investor relations and awards stock options to boost market presence

Executive summary: Vector Science and Therapeutics Corp. entered into an investor‑relations agreement with RedChip Companies, Inc. and granted stock options to certain individuals. The agreement is intended to improve the company’s outreach to investors and potentially support share liquidity, while the options provide incentives tied to the stock’s performance.

Who is involved: Vector Science and Therapeutics Corp. (TSXV: PAIN), RedChip Companies, Inc., and the TSXV exchange.

Likely next: Vector will file the required material‑contract disclosure with the TSXV and begin its IR campaign; RedChip will start outreach to North American institutional investors.

On August 25, 2026, Vector Science and Therapeutics Corp. announced it has engaged RedChip Companies, Inc. to manage its investor‑relations activities and has granted stock options as part of the agreement. The move aims to increase the company’s visibility among institutional investors and align compensation with shareholder interests. No financial terms of the IR contract or the option grant were disclosed in the press release.

Timeline

Analysis — what this means

Sectors affected

Regulatory implications

Sources

Related cases

Browse the full archive →